{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:34:37Z","timestamp":1775014477824,"version":"3.50.1"},"reference-count":48,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1319-2442.178266","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T10:47:29Z","timestamp":1457693249000},"page":"290","source":"Crossref","is-referenced-by-count":9,"title":["Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study"],"prefix":"10.4103","volume":"27","author":[{"given":"FaissalA. M.","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramprasad","family":"Kurpad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AbdullaA","family":"Al-Sayyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MuhammadZiad","family":"Souqiyyeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harith","family":"Aljubori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"El Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqaruddin","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saltanat","family":"Tuganbekova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kairat","family":"Kabulbayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faical","family":"Jarraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/1319-2442.178266-1","first-page":"260","volume-title":"Chronic kidney disease: Global dimension and perspectives","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/1319-2442.178266-2","first-page":"3736","volume-title":"Projecting the number of patients with end-stage renal disease in the United States to the year 2015","author":"Gilbertson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-3","first-page":"S85","volume-title":"Kidney health in the Middle East","author":"Shaheen","year":"2010","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.178266-4","first-page":"38","volume-title":"Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review","author":"Hassanien","year":"2012","journal-title":"JRSM Short Rep"},{"key":"key-10.4103\/1319-2442.178266-5","first-page":"1296","volume-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitallization","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-2442.178266-6","first-page":"440","volume-title":"Cognitive impairment in chronic kidney disease","author":"Madan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.178266-7","first-page":"164","volume-title":"Timing of onset of CKD-related metabolic complications","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-8","first-page":"293","volume-title":"Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance","author":"Stevens","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-9","first-page":"1022","volume-title":"CKD-mineral and bone disorder: core curriculum 2011","author":"Moorthi","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-10","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 113;1S1-130."},{"key":"key-10.4103\/1319-2442.178266-11","first-page":"520","volume-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-12","first-page":"1179","volume-title":"Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.178266-13","first-page":"S1","volume-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","author":"National","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-14","first-page":"622","volume-title":"Comments on \u2032KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2032","author":"Andrassy","year":"2013","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.178266-15","first-page":"35","volume-title":"Gaps between global guidelines and local practices in CKD-MBD","author":"Kim","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"key-10.4103\/1319-2442.178266-16","first-page":"739","volume-title":"K\/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?","author":"Wei","year":"2006","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/1319-2442.178266-17","first-page":"677","volume-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-18","first-page":"171","volume-title":"Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C","author":"Shlipak","year":"2009","journal-title":"Am J Nephrol"},{"key":"key-10.4103\/1319-2442.178266-19","first-page":"10","volume-title":"What do we know about chronic kidney disease in India: first report of the Indian CKD registry","author":"Rajapurkar","year":"2012","journal-title":"BMC Nephrol"},{"key":"key-10.4103\/1319-2442.178266-20","first-page":"52","volume-title":"Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea","author":"Kim","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"key-10.4103\/1319-2442.178266-21","first-page":"480","volume-title":"Vitamin D: calcium and bone homeostasis during evolution","author":"Bouillon","year":"2014","journal-title":"Bonekey Rep"},{"key":"key-10.4103\/1319-2442.178266-22","first-page":"179","volume-title":"Lower risk for cardiovascular mortality in oral 1alphahydroxy Vitamin D3 users in a haemodialysis population","author":"Shoji","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.178266-23","first-page":"1115","volume-title":"Activated injectable Vitamin D and hemodialysis survival: a historical cohort study","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-24","first-page":"374","volume-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","author":"Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-25","first-page":"309","volume-title":"Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow","author":"Malluche","year":"2000","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.178266-26","first-page":"76","volume-title":"Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?","author":"Fraz\u00e3o","year":"2012","journal-title":"BMC Nephrol"},{"key":"key-10.4103\/1319-2442.178266-27","first-page":"E10","volume-title":"Phosphate regulation of vascular smooth muscle cell calcification","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"key-10.4103\/1319-2442.178266-28","first-page":"770","volume-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-29","first-page":"e74996","volume-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","author":"McGovern","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/1319-2442.178266-30","first-page":"812","volume-title":"Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community","author":"Dhingra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"key-10.4103\/1319-2442.178266-31","first-page":"220","volume-title":"Phosphate the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review","author":"Kanbay","year":"2009","journal-title":"Blood Purif"},{"key":"key-10.4103\/1319-2442.178266-32","first-page":"389","volume-title":"Oral phosphate binders in CKD - Is calcium the (only) answer?","author":"Goldsmith","year":"2014","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.178266-33","unstructured":"de Francisco AL. Phosphate binders. Is selection determined by price? Yes. Nefrologia 2012;32:235-9."},{"key":"key-10.4103\/1319-2442.178266-34","first-page":"402","volume-title":"The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?","author":"Cozzolino","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.178266-35","first-page":"593","volume-title":"Aluminum toxicity in patients with chronic renal failure","author":"Alfrey","year":"1993","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/1319-2442.178266-36","first-page":"157","volume-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","author":"Slatopolsky","year":"1986","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-2442.178266-37","first-page":"S107","volume-title":"Control of hyperphosphatemia among patients with ESRD","author":"Coladonato","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-38","first-page":"120","volume-title":"Derangements in phosphate metabolism in chronic kidney diseases\/end-stage renal disease: therapeutic considerations","author":"Molony","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-39","first-page":"132","volume-title":"Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010","author":"Kuznik","year":"2013","journal-title":"BMC Nephrol"},{"key":"key-10.4103\/1319-2442.178266-40","first-page":"103","volume-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-41","first-page":"1014","volume-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","author":"Gu\u00e9rin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.178266-42","first-page":"934","volume-title":"Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease","author":"Vlassara","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.178266-43","first-page":"578","volume-title":"Pharmacology, efficacy and safety of oral phosphate binders","author":"Hutchison","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key-10.4103\/1319-2442.178266-44","first-page":"1815","volume-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.178266-45","first-page":"438","volume-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.178266-46","first-page":"319","volume-title":"Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients","author":"Albaaj","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/1319-2442.178266-47","first-page":"84","volume-title":"Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis","author":"Hill","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.178266-48","first-page":"110","volume-title":"Practice pattern of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients in a tertiary care centre in India","author":"Pavana","year":"2012","journal-title":"Dial Transplant"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T10:50:41Z","timestamp":1457693441000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.sjkdt.org\/text.asp?2016\/27\/2\/290\/178266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["178266"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.178266","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}